Showing results (1731-1740 of 9,980) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|June 3, 2021
Hsa-miR-372-5p regulates the NIMA related kinase 7 and IL-1β release in NK/T-cell lymphomaQi Chen, Shenglin Liu, Kaoyuan Zhang, et al.Leukemia & Lymphoma|November 16, 2020
Clinical application of next generation sequencing in lymphomaAnthony J Scott, Molly C Tokaz, Maryann Shango, et al.Leukemia & Lymphoma|December 17, 2020
Reduction of immunosuppression for post-transplant lymphoproliferative disorder (PTLD): a single-center experience of allograft survival outcomesKelsey Pan, Aaron J Franke, William Paul Skelton, et al.Leukemia & Lymphoma|January 4, 2021
In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapySusan L Heatley, Kartini Asari, Caitlin E Schutz, et al.Leukemia & Lymphoma|February 18, 2020
Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levelsValeria Santini, Antonio Almeida, Aristoteles Giagounidis, et al.Leukemia & Lymphoma|February 7, 2020
Wide variation in use and interpretation of gene mutation profiling panels among health care providers of patients with myelodysplastic syndromes: results of a large web-based surveyAlexander B Pine, Nora Chokr, Maximilian Stahl, et al.Leukemia & Lymphoma|February 8, 2020
Venetoclax in acute myeloid leukemia - current and future directionsCurtis Lachowiez, Courtney D DiNardo, Marina KonoplevaLeukemia & Lymphoma|February 8, 2020
A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairmentYing C Ou, Richard A Preston, Thomas C Marbury, et al.Leukemia & Lymphoma|February 11, 2020
LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agentsKelly S Chien, Caleb A Class, Guillermo Montalban-Bravo, et al.Leukemia & Lymphoma|February 28, 2020
A systematic review of therapeutic regimens for older patients with newly diagnosed Hodgkin lymphomaPamela B Allen, Amy Ayers, Madhusmita Behera, et al.Pageof 998